DISA Limited Expands Healthcare Reach with New AVAT Device Trial

Tip Ranks
2025.11.20 12:12
portai
I'm PortAI, I can summarize articles.

DISA Limited's subsidiary, Digital Life Line, has started a clinical trial for its Automated Visual Acuity Test (AVAT) device at Ng Teng Fong General Hospital. The trial aims to expand the device's market reach beyond specialist centers by demonstrating its effectiveness in a high-volume hospital. The AVAT device, which allows self-administered eye exams, has already improved efficiency at Singapore’s National University Hospital. This move is expected to create a new revenue stream and meet the growing demand for ophthalmological services.

TipRanks Black Friday Sale

  • Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
  • Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off

DISA ( (SG:532) ) has shared an announcement.

DISA Limited’s subsidiary, Digital Life Line, has initiated a clinical trial for its Automated Visual Acuity Test (AVAT) device at Ng Teng Fong General Hospital. This trial aims to demonstrate the device’s effectiveness in a high-volume community hospital, potentially expanding its market beyond tertiary specialist centers. The AVAT device, which allows patients to self-administer eye exams, has already shown success at Singapore’s National University Hospital by improving workflow efficiency and reducing patient wait times. This strategic move is expected to create a new revenue stream and address the growing demand for ophthalmological services in mainstream healthcare settings.

More about DISA

DISA Limited, incorporated in Singapore, operates in the healthcare technology industry through its subsidiary Digital Life Line Pte. Ltd. The company focuses on developing automated medical devices, with a primary emphasis on visual acuity testing solutions aimed at enhancing efficiency in healthcare settings.

Current Market Cap: S$14.09M

Find detailed analytics on 532 stock on TipRanks’ Stock Analysis page.